American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Galera Therapeutics, Inc. (GRTX)

$17.60 -2.22% OTC: GRTX · 15-min delayed

MALVERN, Pennsylvania
Public · OTC: GRTX

Visit website Follow

$149.0MNet income

GRTXOTC

About Galera Therapeutics, Inc.

GALERA THERAPEUTICS INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: GRTX
Headquarters: MALVERN, Pennsylvania
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: GRTX OTC
SEC CIK: 1563577
EIN: 461454898
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show Galera Therapeutics, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/galera-therapeutics-inc/"><img src="https://americancompanies.com/badge/galera-therapeutics-inc.svg" alt="Galera Therapeutics, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Galera Therapeutics, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Net income: $149.0M
Total assets: $7.2M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

FY2019

FY2020

FY2021

FY2022

FY2023

Revenue Net income

FY 2023

Financial statements

Income statement

Operating income: -$49.3M
Income tax: $0
Net income: -$59.1M

Balance sheet

Total assets: $26.1M
Current assets: $21.6M
Total liabilities: $157.3M
Current liabilities: $5.0M
Shareholders’ equity: -$131.2M

Cash flow

Operating cash flow: -$44.8M
Investing cash flow: $27.3M
Financing cash flow: $31.5M
Net cash flow: $13.9M

Statements via Polygon.io (SEC filings)

OTC: GRTX

$17.60 -2.22%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.20 $20.96

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Galera Therapeutics, Inc. (GRTX) Stock Price

Profitable — net income of $149.0M.
Trading 16% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Galera Therapeutics, Inc..

Write a review

Newsroom

News about Galera Therapeutics, Inc.

Halper Sadeh LLC is Investigating Whether LEG, AVNS, SEM, GRTX are Obtaining Fair Deals for their Shareholders GlobeNewswire Inc. · 2026-04-23 · negative Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement Benzinga · 2026-04-14 · neutral $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Galera Therapeutics, Inc. (OTCMKTS: GRTX) GlobeNewswire Inc. · 2026-04-14 · negative Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million GlobeNewswire Inc. · 2025-10-22 · neutral Kailera Therapeutics Launches with $400 Million Series A Financing to Advance Portfolio of Next-Generation Therapies for Obesity and Related Conditions GlobeNewswire Inc. · 2024-10-01 · positive Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates GlobeNewswire Inc. · 2024-05-13

News & sentiment via Polygon.io

FAQ

Galera Therapeutics, Inc.: frequently asked questions

Is Galera Therapeutics, Inc. an American company?

Galera Therapeutics, Inc. is a US-based company headquartered in Malvern, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Galera Therapeutics, Inc. headquartered?

Galera Therapeutics, Inc. is headquartered in Malvern, Pennsylvania, United States.

Is Galera Therapeutics, Inc. publicly traded?

Yes — Galera Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol GRTX on the OTC.

What does Galera Therapeutics, Inc. do?

Galera Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore